BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dilazep

Dilazep Coronary vasodilator with some antiarrhythmic activity.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 43.2

Research Domains

Dilazep has been studied across 17 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🦴 Bone & Joint, 🔥 Metabolic, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 21% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dilazep, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Polidocanol
16 shared targets
Itraconazole
13 shared targets
Melphalan
18 shared targets
lidoflazine
16 shared targets
Oxymetholone
15 shared targets
Ethynodiol
15 shared targets
Melengestrol
12 shared targets
Dydrogesterone
11 shared targets
oxatomide
18 shared targets
Thioinosine
11 shared targets
Loading evidence profile...

This evidence profile for Dilazep is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.